Evonik Health Care
Birmingham, AL · Vancouver, BC
Compare mRNA/LNP CDMOs in Europe
Compare mRNA/LNP CDMOs in Germany
Compare Biologics CDMOs in Europe
Compare Biologics CDMOs in Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
81.5
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
✓ MHRA GMP (2)
Quick Facts: Evonik Health Care
- Signal Score
- 81.5/100 (as of 2026-10-29)
- Quality Compliance
- 99.8/100
- Headquarters
- Birmingham, AL · Vancouver, BC
- Modalities
- mRNA, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Evonik Health Care
LNP formulation and drug delivery CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
99.8
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-09-11)
MHRA GMP Certificates2 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: Evonik Industries (EVK.DE)
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Evonik Industries (EVK.DE)
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Birmingham, AL, Vancouver, BC
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals2 articles (not scored)
2 manufacturing sites
Evonik Health Care FDA Inspection History
2025-09
2024-12
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-09-11 |
Evonik Corporation
Lafayette, Indiana
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2024-12-10 |
Evonik Corporation
Birmingham, Alabama
Facility-linked
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 22, 2026
Evonik Health Care MHRA GMP Compliance 2 certificates
2016-05
2016-05
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK GMP 36752 Insp GMP 36752/7750465-0002 [H] | EVONIK CORPORATION | 35211 | 2016-05-09 | COMPLIANT |
| UK GMP 36752 Insp GMP 36752/7750465-0002 [V] | EVONIK CORPORATION | 35211 | 2016-05-09 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Nov 22, 2026
Japan-accredited overseas site (PMDA)
general (non-sterile) · 1 site
- Lafayette, United States · Evonik Corporation — general (non-sterile) · valid to Mar 3, 2030
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 21, 2026
Company Signals 2 articles
Company announcements, not verified evidence. They do not change any score.
Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia - ChemAnalyst
Evonik Boosts Biotechnology Capacity for Drug Substance Production Through New Investment in Slovakia ChemAnalyst
Evonik expands biotechnology capabilities in Slovakia - The Chemical Engineer
Evonik expands biotechnology capabilities in Slovakia The Chemical Engineer
Frequently Asked Questions About Evonik Health Care
How many FDA inspections does Evonik Health Care have on record?
CDMO Signal tracks 2 FDA inspections for Evonik Health Care, sourced from the FDA inspection database. See the full inspection history above.
Has Evonik Health Care received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Evonik Health Care.
Does Evonik Health Care hold EMA or MHRA GMP certificates?
CDMO Signal tracks 2 MHRA GMP certificates for Evonik Health Care.
What is Evonik Health Care's CDMO Signal Score?
Evonik Health Care has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Evonik Health Care for a manufacturing program?
Use the free AI matchmaker to compare Evonik Health Care against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Compare Evonik Health Care with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.